Moreover, it could be demonstrated that CD36 expression is upregulated in the livers of MASLD patients, leading to hepatic triglyceride accumulation and consequently an exacerbation of hepatic steatosis (Pei et al., 2020). This evidence concerns the gene CD36 and fatty liver disease.